03/21/2025 8:00 AM | Janus Henderson Group (Filer)
| Form ARS | |
03/21/2025 8:01 AM | Janus Henderson Group (Filer)
| Form DEF 14A | |
03/21/2025 8:02 AM | Janus Henderson Group (Filer)
| Form DEFA14A | |
03/07/2025 11:58 AM | Janus Henderson Group (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
03/04/2025 1:53 PM | FOGO GEORGINA (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 1:54 PM | Janus Henderson Group (Issuer) LOWRY JAMES R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 1:56 PM | Janus Henderson Group (Issuer) THOMPSON ROGER MJ (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:12 PM | CRAWFORD BERG (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:18 PM | CASSIDY WILLIAM B (Reporting) Janus Henderson Group (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 4:00 PM | Janus Henderson Group (Filer)
| Form PRE 14A | |
02/27/2025 3:31 PM | Janus Henderson Group (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for JHG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Janus Henderson Group and its competitors with MarketBeat's FREE daily newsletter.
|
02/25/2025 11:15 PM | Janus Henderson Group (Filer) Janus Henderson US Inc. (0002043380) (Filer)
| Form EFFECT | |
02/25/2025 3:31 PM | Janus Henderson Group (Filer) Janus Henderson US Inc. (0002043380) (Filer)
| Form 424B3 | |
02/14/2025 11:57 AM | ARDELYX, INC. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:58 AM | Akero Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 12:03 PM | Consensus Cloud Solutions, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:25 AM | CARGO Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:25 AM | Aramark (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:33 AM | Janus Henderson Group (Filer)
| Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/14/2025 11:33 AM | Janus Henderson Group (Filed by) Zai Lab Ltd (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:34 AM | AMDOCS LTD (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:34 AM | GLOBUS MEDICAL INC (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:35 AM | BLACKBAUD INC (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:35 AM | Immunome Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:35 AM | Janus Henderson Group (Filed by) Walker & Dunlop, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:36 AM | Janus Henderson Group (Filed by) LIGAND PHARMACEUTICALS INC (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:36 AM | Janus Henderson Group (Filed by) RENTOKIL INITIAL PLC /FI (Subject) RENTOKIL INITIAL PLC /FI (Subject) RENTOKIL INITIAL PLC /FI (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:36 AM | Janus Henderson Group (Filed by) SENSIENT TECHNOLOGIES CORP (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:37 AM | Janus Henderson Group (Filed by) REVVITY, INC. (Subject) REVVITY, INC. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:37 AM | Benitec Biopharma Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:37 AM | Janus Henderson Group (Filed by) TENAX THERAPEUTICS, INC. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:22 AM | Janus Henderson Group (Filed by) OSI SYSTEMS INC (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:22 AM | Janus Henderson Group (Filed by) Structure Therapeutics Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:22 AM | Dyne Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:23 AM | Biohaven Ltd. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:23 AM | FLEX LTD. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:24 AM | IDEAYA Biosciences, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:24 AM | Janus Henderson Group (Filed by) SS&C Technologies Holdings Inc (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:24 AM | Janus Henderson Group (Filed by) Sensata Technologies Holding plc (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:25 AM | ASURE SOFTWARE INC (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:04 AM | Janus Henderson Group (Filed by) TELEFLEX INC (Subject)
| Form SCHEDULE 13G/A | |
Trump’s Secret Weapon (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today |
02/14/2025 11:09 AM | Janus Henderson Group (Filed by) Mirum Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:09 AM | Janus Henderson Group (Filed by) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject) Liberty Media Corp (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:10 AM | Janus Henderson Group (Filed by) WEX Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:10 AM | Janus Henderson Group (Filed by) MADRIGAL PHARMACEUTICALS, INC. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:10 AM | ICU MEDICAL INC/DE (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 11:11 AM | Janus Henderson Group (Filed by) Mirum Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:11 AM | Janus Henderson Group (Filed by) Lantheus Holdings, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:12 AM | Janus Henderson Group (Filed by) Vaxcyte, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 11:12 AM | Janus Henderson Group (Filed by) ZIFF DAVIS, INC. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:54 AM | Ascendis Pharma A/S (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:55 AM | AVADEL PHARMACEUTICALS PLC (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:55 AM | Janus Henderson Group (Filed by) Lexeo Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:55 AM | CIMPRESS plc (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:56 AM | Janus Henderson Group (Filed by) SOLENO THERAPEUTICS INC (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:24 AM | Janus Henderson Group (Filed by) Janux Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
02/14/2025 10:24 AM | Avidity Biosciences, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G | |
02/14/2025 10:24 AM | Edgewise Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G | |
02/14/2025 10:25 AM | Janus Henderson Group (Filed by) Revolution Medicines, Inc. (Subject) Revolution Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
02/14/2025 10:25 AM | Forte Biosciences, Inc. (Subject) Forte Biosciences, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G | |
02/14/2025 10:25 AM | Entrada Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G | |
02/14/2025 10:34 AM | CytomX Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:34 AM | Janus Henderson Group (Filed by) Neurogene Inc. (Subject) Neurogene Inc. (Subject) Neurogene Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:34 AM | 4D Molecular Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:35 AM | Janus Henderson Group (Filed by) NEOGENOMICS INC (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:35 AM | Janus Henderson Group (Filed by) PRECISION BIOSCIENCES INC (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:35 AM | Caesars Entertainment, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:36 AM | IMMUNIC, INC. (Subject) IMMUNIC, INC. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:36 AM | Janus Henderson Group (Filed by) PepGen Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:36 AM | Applied Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 10:37 AM | Janus Henderson Group (Filed by) Perspective Therapeutics, Inc. (Subject) Perspective Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025 10:23 AM | Janus Henderson Group (Filed by) Protara Therapeutics, Inc. (Subject) Protara Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
02/07/2025 6:50 PM | Capital Research Global Investors (Filed by) Janus Henderson Group (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025 9:49 AM | BRIGHT MINDS BIOSCIENCES INC. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G | |
02/07/2025 9:48 AM | Beauty Health Co (Subject) Beauty Health Co (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025 9:49 AM | 89bio, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025 6:30 AM | Janus Henderson Group (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2025 1:24 PM | Janus Henderson Group (Filed by) Surgery Partners, Inc. (Subject)
| Form SCHEDULE 13G | |
01/21/2025 3:31 PM | Janus Henderson Group (Filer) Janus Henderson US Inc. (0002043380) (Filer)
| Form S-4/A | |
01/08/2025 10:49 AM | Janus Henderson Group (Filed by) Larimar Therapeutics, Inc. (Subject) Larimar Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
01/08/2025 10:38 AM | Janus Henderson Group (Filed by) Monopar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/08/2025 7:34 AM | Janus Henderson Group (Issuer) PODZOROV MEGAN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/13/2024 3:34 PM | Janus Henderson Group (Filer) Janus Henderson US Inc. (0002043380) (Filer)
| Form S-4/A | |
12/06/2024 12:47 PM | Benitec Biopharma Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
12/06/2024 10:36 AM | ARDELYX, INC. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
12/06/2024 10:36 AM | Applied Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SCHEDULE 13G/A | |
12/06/2024 10:37 AM | Janus Henderson Group (Filed by) Mereo BioPharma Group plc (Subject)
| Form SCHEDULE 13G/A | |
11/18/2024 3:34 PM | Janus Henderson Group (Filer) Janus Henderson US Inc. (0002043380) (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |
11/14/2024 2:13 PM | IDEAYA Biosciences, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:15 PM | 4D Molecular Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:16 PM | CARGO Therapeutics, Inc. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
The Tech Industry Is ABOUT to Boom! (Ad) Discover why Notable Names like Cisco, Hewlett Packard and New York Life are Choosing to Do Business with this Growing Marketing Tech Company
While the overall market has been turbulent in 2025, one space seeing significant advancements and widespread adoption is AI. Artificial intelligence is predicted to shift the world tremendously in the years to come. Industries will be radically transformed. This NASDAQ-traded small cap company should be high on your radar as it emerges as the next leader in bringing AI into the massive marketing arena. With over 1250 customers added alone in 2024, They are attracting quite the following, including Fortune 500 companies who want marketing tools that enable their brand to grow effortlessly. The company’s client list includes big names like Cisco, New York Life, Hewlett Packard Enterprise, Thermo Fisher Scientific, Thinkific, Doodle and ActiveCampaign, among thousands of others! See how This NASDAQ Company is aiming to lead the AI movement while building shareholder value. |
11/14/2024 2:17 PM | AMDOCS LTD (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:19 PM | Janus Henderson Group (Filed by) LIGAND PHARMACEUTICALS INC (Subject)
| Form SC 13G/A | |
11/14/2024 2:20 PM | BLACKBAUD INC (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:24 PM | Janus Henderson Group (Filed by) Neurogene Inc. (Subject) Neurogene Inc. (Subject) Neurogene Inc. (Subject)
| Form SC 13G/A | |
11/14/2024 1:55 PM | Janus Henderson Group (Filed by) ZIFF DAVIS, INC. (Subject)
| Form SC 13G/A | |
11/14/2024 1:57 PM | Ascendis Pharma A/S (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:05 PM | FLEX LTD. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:06 PM | Biohaven Ltd. (Subject) Janus Henderson Group (Filed by)
| Form SC 13G/A | |
11/14/2024 2:08 PM | Janus Henderson Group (Filed by) SS&C Technologies Holdings Inc (Subject)
| Form SC 13G/A | |